Changes in the global burden of polycystic ovary syndrome from 1990 to 2021
Research Square (Research Square),
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 17, 2025
Abstract
BACKGROUND
Polycystic
ovary
syndrome
(PCOS)
is
a
chronic,
multifaceted
condition
influenced
by
epigenetic
and
environmental
factors
that
responsible
for
significant
proportion
of
anovulatory
infertility
cases.
Here,
we
analyzed
the
global,
regional,
national
burdens
PCOS
from
1990
to
2021
using
data
Global
Burden
Disease
(GBD
2021).
METHODS
Incidence,
prevalence,
Disability-Adjusted
Life
Years(DALYs)
relevant
204
countries
21
territories
were
obtained
GBD
study.
considered
age-standardized
rates
(per
100,000
individuals)
with
95%
uncertainty
intervals
(95%
UIs)
aforementioned
research
presented
trends
based
on
age
Socio-demographic
Index
(SDI)
parameters.
RESULTS
incidence
prevalence
in
reported
at
30.7
867.7
per
100,000,
respectively,
revealing
increases
26.77%
28.21%,
since
1990.
Additionally,
disability-adjusted
life
years
stood
7.6
globally
2021,
marking
27.58%
increase
Age-standardized
varied
across
countries,
ranging
93.1
3978.9
cases
women,
Italy
(3978.9),
Japan
(3104.7),
New
Zealand
(2789.7)
having
highest
rates.
Notably,
was
noted
peak
among
females
15–19
age.
Regions
high
SDI
exhibited
(70.2),
(1720.7),
death
(15.2)
PCOS.
Furthermore,
nonlinear
correlation
between
burden
noted,
peaking
around
an
approximately
0.9.
CONCLUSION
Our
findings
highlight
growing
global
impact
underscore
need
concerted
efforts
attenuate
increasing
this
condition.
Significantly
divergent
disease
observed
different
groups
regions,
regions
bearing
heavier
burdens.
The
increased
younger
regional
disparities
urgency
targeted
intervention
formulation
policies
effectively
address
public
health
issue.
Язык: Английский
Quinoa ameliorates polycystic ovary syndrome via regulating gut microbiota through PI3K/AKT/mTOR pathway and autophagy
Nutrition & Metabolism,
Год журнала:
2024,
Номер
21(1)
Опубликована: Окт. 11, 2024
Polycystic
ovary
syndrome
(PCOS)
is
a
unity
of
endocrine
and
metabolic
disorders,
associated
with
PI3K/AKT/mTOR,
autophagy,
gut
microbiota.
Quinoa
valuable
food
source,
which
contains
rich
minerals,
unsaturated
fatty
acids,
has
positive
modulating
effect
on
diseases.
However,
its
effects
potential
mechanisms
PCOS
have
not
been
reported
yet.
Therefore,
the
purpose
this
study
to
investigate
quinoa
rats
by
regulating
Ten–week-old
female
Sprague-Dawley
(SD)
received
letrozole
for
24
days
induction
subsequently
were
treated
diet
8
weeks.
Vaginal
smears
used
analyze
estrous
cycle
rats.
Hormone
biochemical
indexes
analyzed
kit
assays
glucometer.
The
pathological
changes
ovary,
pancreas,
duodenum
colon
observed
HE
staining.
PI3K,
AKT,
mTOR
autophagy-related
proteins
in
measured
western
blot
immunohistochemistry
Tight
junction
16
s
rDNA
sequencing
was
detect
intestinal
microbiota
Network
pharmacology
molecular
docking
possible
targets
PCOS.
Spearman
correlation
analysis
relationship
between
microbial
abundance
hormone
levels
at
phylum
genus
level.
significantly
improved
parameters
PCOS-like
rats,
state
tissues.
Especially,
regulated
expression
ovary.
may
repair
barrier
upregulating
tight
colon,
regulate
factors
colon.
Additionally,
increased
Lactobacillu,
Bacteroides
Oscillospira,
decreased
Firmicutes/Bacteroidetes
ratio
Blautia,
Prevotella,
reversing
dysregulation
Correlation
showed
that
there
strong
significant
related
Our
result
indicated
maybe
activation
PI3K/AKT/mTOR
signaling
pathway,
inhibition
regulation
flora.
Язык: Английский